InvestorsHub Logo
Followers 24
Posts 2292
Boards Moderated 0
Alias Born 03/18/2013

Re: ggwpq post# 403432

Friday, 02/17/2023 12:16:08 PM

Friday, February 17, 2023 12:16:08 PM

Post# of 429056
qq: It depends upon the acquiring company's cash position. Novartis (Yahoo) says it has $18.73B in cash. More than enough to acquire us using cash. But, if they needed their cash for expansion and marketing, then @ $83 per share they could issue 73 million shares (approx. $6B) a virtual drop (not really) in the bucket to their outstanding 2.12Bshares. A 3.4% dilution. I can definitely see your point. However.....

Novartis would then be in the drivers seat in the Cardiovascular arena.

If it were me I'd accept cash and shares and call it good. Novartis pays a 4% dividend. I'd be a happy clam for sure.

BTW, $6B gets us approx. a $15 buyout price, within my range for sure.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News